[March 05, 2015] |
|
Research and Markets: Depression - Pipeline Review, H1 2015: Featuring over 80 Companies
Research and Markets (http://www.researchandmarkets.com/research/dcl5hm/depression)
has announced the addition of the "Depression
- Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Depression, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for
Depression and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Depression Overview
-
Therapeutics Development
-
Depression - Therapeutics under Development by Companies
-
Depression - Therapeutics under Investigation by
Universities/Institutes
-
Depression - Pipeline Products Glance
-
Depression - Products under Development by Companies
-
Depression - Products under Investigation by Universities/Institutes
-
Depression - Companies Involved in Therapeutics Development
-
Depression - Therapeutics Assessment
-
Drug Profiles
-
Depression - Recent Pipeline Updates
-
Depression - Dormant Projects
-
Depression - Discontinued Products
-
Depression - Product Development Milestones
-
Appendix
Companies Mentioned - 30 of the 80+ Companies Featured
-
AB Science
-
Acetylon Pharmaceuticals, Inc.
-
Ache Laboratorios Farmaceuticos S/A
-
Adamas Pharmaceuticals, Inc.
-
Adamed Sp. z o.o.
-
Addex Therapeutics Ltd
-
Alkermes Plc
-
Allergan, Inc.
-
Anavex Life Sciences Corp.
-
Angelini Group
-
Angita B.V.
-
Ascendis Pharma A/S
-
AstraZeneca PLC
-
Avanir Pharmaceuticals, Inc.
-
Azevan Pharmaceuticals, Inc.
-
Beech Tree Labs, Inc.
-
BioCrea GmbH
-
Bionomics Limited
-
Boehringer Ingelheim GmbH
-
Bristol-Myers Squibb Company
-
Calico LLC
-
Cerecor Inc.
-
Clera Inc.
-
Concert Pharmaceuticals, Inc.
-
Convergence (News - Alert) Pharmaceuticals Ltd.
-
D-Pharm Ltd.
-
Delpor, Inc.
-
Domain Therapeutics SA
-
e-Therapeutics plc
-
Edgemont Pharmaceuticals, LLC
For more information visit http://www.researchandmarkets.com/research/dcl5hm/depression
[ Back To TMCnet.com's Homepage ]
|